文献速递神经MR

脑胶质瘤磁敏感加权成像应用进展

An update on susceptibility-weighted imaging in brain gliomas.
PubMed 文献 · Eur Radiol · 2024-04-06

本文综述了磁敏感加权成像(SWI)在脑胶质瘤评估中的应用。SWI是检测脑内出血和钙化最敏感的序列,通过检测肿瘤内磁敏感信号(ITSS)有助于胶质瘤的诊断、表征和分级,并可能预测治疗反应和监测治疗后变化。增强前后SWI的附加价值及未来方向也被探讨。

要点

  • SWI是检测脑内出血和钙化最敏感的序列,已成为多数脑MRI协议的標準組成部分。
  • SWI通过检测肿瘤内磁敏感信号(ITSS)的数量、分布和特征,有助于胶质瘤的诊断、表征和分级。
  • 增强前后采集SWI可能为胶质瘤评估提供附加价值,并可能用于预测治疗反应和治疗后监测。

核心结论

  • SWI在胶质瘤评估中有效,尤其是通过评估肿瘤内磁敏感信号变化;它正成为一种有前景且易于整合的工具,可用于治疗前和治疗后评估的MRI协议中。

研究设计与样本

  • 综述,总结了关于SWI在脑胶质瘤评估中应用的研究,检索范围和纳入文献标准原文未报告。

关键影像表现/征象

  • 肿瘤内磁敏感信号(ITSS)提示肿瘤内微出血和血管,其数量、分布和特征可为放射科医生提供更精确的评估信息。
  • SWI有助于将胶质瘤与其他脑病变(如原发性中枢神经系统淋巴瘤或转移瘤)进行鉴别。
  • 增强前后采集SWI有助于胶质瘤的诊断、表征和分级。

临床应用与阅片要点

  • 原文建议将SWI作为辅助序列用于预测治疗反应和治疗后监测。
  • 原文指出SWI是检测脑内出血和钙化最敏感的序列,增强前后采集有助于胶质瘤诊断、表征和分级。
  • 原文提到在胶质瘤评估中应用SWI仍存在持续挑战,需加以面对以明确其作用。

局限性

  • 原文指出在胶质瘤评估中应用SWI仍存在持续挑战,需加以面对以明确其作用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Susceptibility-weighted imaging (SWI) has become a standard component of most brain MRI protocols. While traditionally used for detecting and characterising brain hemorrhages typically associated with stroke or trauma, SWI has also shown promising results in glioma assessment. Numerous studies have highlighted SWI's role in differentiating gliomas from other brain lesions, such as primary central nervous system lymphomas or metastases. Additionally, SWI aids radiologists in non-invasively grading gliomas and predicting their phenotypic profiles. Various researchers have suggested incorporating SWI as an adjunct sequence for predicting treatment response and for post-treatment monitoring. A significant focus of these studies is on the detection of intratumoural susceptibility signals (ITSSs) in gliomas, which are indicative of microhemorrhages and vessels within the tumour. The quantity, distribution, and characteristics of these ITSSs can provide radiologists with more precise information for evaluating and characterising gliomas. Furthermore, the potential benefits and added value of performing SWI after the administration of gadolinium-based contrast agents (GBCAs) have been explored. This review offers a comprehensive, educational, and practical overview of the potential applications and future directions of SWI in the context of glioma assessment. CLINICAL RELEVANCE STATEMENT: SWI has proven effective in evaluating gliomas, especially through assessing intratumoural susceptibility signal changes, and is becoming a promising, easily integrated tool in MRI protocols for both pre- and post-treatment assessments. KEY POINTS: • Susceptibility-weighted imaging is the most sensitive sequence for detecting blood and calcium inside brain lesions. • This sequence, acquired with and without gadolinium, helps with glioma diagnosis, characterisation, and grading through the detection of intratumoural susceptibility signals. • There are ongoing challenges that must be faced to clarify the role of susceptibility-weighted imaging for glioma assessment.

来源:Eur Radiol,查看原文。版权归原作者所有。

引用

  1. Martín-Noguerol T, Santos-Armentia E, Ramos A, et al. An update on susceptibility-weighted imaging in brain gliomas. Eur Radiol. 2024. PMID: 38581609. doi:10.1007/s00330-024-10703-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。